- Home
- ABAT vs IOBT Comparison
ABAT vs IOBT Comparison
Compare ABAT & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABAT
- IOBT
- Stock Information
- Founded
- ABAT 2011
- IOBT 2014
- Country
- ABAT United States
- IOBT Denmark
- Employees
- ABAT N/A
- IOBT N/A
- Industry
- ABAT Metal Mining
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- ABAT Basic Materials
- IOBT Health Care
- Exchange
- ABAT Nasdaq
- IOBT Nasdaq
- Market Cap
- ABAT 87.2M
- IOBT 91.6M
- IPO Year
- ABAT N/A
- IOBT 2021
- Fundamental
- Price
- ABAT $1.63
- IOBT $1.72
- Analyst Decision
- ABAT
- IOBT Strong Buy
- Analyst Count
- ABAT 0
- IOBT 3
- Target Price
- ABAT N/A
- IOBT $9.33
- AVG Volume (30 Days)
- ABAT 2.7M
- IOBT 176.5K
- Earning Date
- ABAT 05-16-2025
- IOBT 08-12-2025
- Dividend Yield
- ABAT N/A
- IOBT N/A
- EPS Growth
- ABAT N/A
- IOBT N/A
- EPS
- ABAT N/A
- IOBT N/A
- Revenue
- ABAT $1,857,877.00
- IOBT N/A
- Revenue This Year
- ABAT $31,748.62
- IOBT N/A
- Revenue Next Year
- ABAT N/A
- IOBT N/A
- P/E Ratio
- ABAT N/A
- IOBT N/A
- Revenue Growth
- ABAT N/A
- IOBT N/A
- 52 Week Low
- ABAT $0.73
- IOBT $0.66
- 52 Week High
- ABAT $4.11
- IOBT $1.73
- Technical
- Relative Strength Index (RSI)
- ABAT 55.11
- IOBT 53.11
- Support Level
- ABAT $1.78
- IOBT $1.34
- Resistance Level
- ABAT $2.04
- IOBT $1.47
- Average True Range (ATR)
- ABAT 0.19
- IOBT 0.10
- MACD
- ABAT 0.01
- IOBT -0.01
- Stochastic Oscillator
- ABAT 52.44
- IOBT 52.00
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.